Literature DB >> 7420269

Gastrointestinal absorption of quinidine from some solutions and commercial tablets.

T W Guentert, R A Upton, N H Holford, A Bostrom, S Riegelman.   

Abstract

The gastrointestinal absorption of quinidine from three commercially available tablet products has been compared to that from a quinidine sulfate solution previously found to have 70% of the systematic availability of an intravenous dose. Quinidine gluconate solution was included in the study to compare the absorption characteristics of the two quinidine salts. The tablets were given in a counterbalanced sequence preceded by one quinidine solution and followed by the other in a crossover design. The three tablets proved to be equivalent to one another with respect to extent and rate of absorption. The absorption properties of the two solutions were indistinguishable. The tablets were equivalent to the solutions in extent but not in rate of absorption.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7420269     DOI: 10.1007/bf01059645

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  10 in total

1.  Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.

Authors:  D E Drayer; K Restivo; M M Reidenberg
Journal:  J Lab Clin Med       Date:  1977-11

2.  Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

Authors:  D J Greenblatt; H J Pfeifer; H R Ochs; K Franke; D S MacLaughlin; T W Smith; J Koch-Weser
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

3.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

4.  Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate.

Authors:  H R Ochs; D J Greenblatt; E Woo; K Franke; H J Pfeifer; T W Smith
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

5.  Specificity of quinidine determination methods.

Authors:  T W Guentert; S Riegelman
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

6.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

7.  Absolute quinidine bioavailability.

Authors:  C T Ueda; B J Williamson; B S Dzindzio
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

8.  Determination of quinidine and its major metabolites by high-performance liquid chromatography.

Authors:  T W Guentert; P E Coates; R A Upton; D L Combs; S Riegelman
Journal:  J Chromatogr       Date:  1979-01-01

9.  Blood collection techniques, heparin and quinidine protein binding.

Authors:  K M Kessler; R C Leech; J F Spann
Journal:  Clin Pharmacol Ther       Date:  1979-02       Impact factor: 6.875

10.  Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.

Authors:  T W Guentert; N H Holford; P E Coates; R A Upton; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1979-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.